The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
2066997 |
93 |
Calcium channel blocking and positive inotropic activities of ethyl 5-cyano-1,4-dihydro-6-methyl-2-[(phenylsulfonyl)methyl]-4-aryl-3- pyridine-carboxylate and analogues. Synthesis and structure-activity relationships. |
Warner-Lambert |
2552119 |
6 |
Dihydropyrimidines: novel calcium antagonists with potent and long-lasting vasodilative and antihypertensive activity. |
Suntory Institute For Biomedical Research |
2840504 |
21 |
2-(2-Aryl-2-oxoethylidene)-1,2,3,4-tetrahydropyridines. Novel isomers of 1,4-dihydropyridine calcium channel blockers. |
Warner-Lambert |
3023614 |
8 |
Stereoselectivity of a potent calcium antagonist, 1-benzyl-3-pyrrolidinyl methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate. |
TBA |
20064722 |
6 |
Synthesis and biological activity of the calcium modulator (R) and (S)-3-methyl 5-pentyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate. |
Fourth Military Medical University |
| 5 |
(cis)-3-methyl-1,5-benzothiazepine-4-ones: potent analogs of the calcium channel blocker diltiazen |
TBA |
8831775 |
34 |
New purines and purine analogs as modulators of multidrug resistance. |
Institut De Recherches Servier |
28068085 |
4 |
Cyclocurcumin, an Antivasoconstrictive Constituent of Curcuma longa (Turmeric). |
Seoul National University |
21514827 |
5 |
Asymmetric synthesis and biological evaluations of (+)- and (-)-6-dimethoxymethyl-1,4-dihydropyridine-3-carboxylic acid derivatives blocking N-type calcium channels. |
Ajinomoto Pharmaceuticals |
19831392 |
3 |
Stereoselective behavior of the functional diltiazem analogue 1-[(4-chlorophenyl)sulfonyl]-2-(2-thienyl)pyrrolidine, a new L-type calcium channel blocker. |
Universita Degli Studi Di Perugia |
19323482 |
8 |
L-Type calcium channel blockers: from diltiazem to 1,2,4-oxadiazol-5-ones via thiazinooxadiazol-3-one derivatives. |
Universita Degli Studi Di Bologna |
18754582 |
3 |
Discovery of novel and cardioselective diltiazem-like calcium channel blockers via virtual screening. |
Universit£ |
18684623 |
16 |
The structure-activity relationship study on 2-, 5-, and 6-position of the water soluble 1,4-dihydropyridine derivatives blocking N-type calcium channels. |
Ajinomoto |
12880313 |
33 |
Simplified tetrandrine congeners as possible antihypertensive agents with a dual mechanism of action. |
Universidad De Chile |
16309909 |
54 |
Structure-activity relationship study of 1,4-dihydropyridine derivatives blocking N-type calcium channels. |
Ajinomoto |
12166948 |
77 |
Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as use-dependent sodium channel blockers for the treatment of stroke. |
Boehringer Ingelheim Pharma |
10602711 |
3 |
Vasorelaxation by new hybrid compounds containing dihydropyridine and pinacidil-like moieties. |
National Academy of Sciences of Ukraine |
9651170 |
189 |
Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate. |
New York University Medical Center |
30049584 |
6 |
Terpenoids with vasorelaxant effects from the Chinese liverwort Scapania carinthiaca. |
Shandong University |
1311765 |
38 |
Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site. |
Bristol-Myers Squibb Pharmaceutical Research Institute |